Latest Feature

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Sequent Medical CEO Wilder bets on braids

Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pus

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Integra launches regenerative burn treatment

December 18, 2014 by Val Kennedy

Integra Lifesciences launches its latest skin-regeneration product for 3rd-degree burns and scar contractures that haven't responded to other therapies.

Integra launches regenerative burn treatment

EU's top court opens door to some stem cell patents

December 18, 2014 by MassDevice

Europe's top court today opened the door to stem cell patents in the European Union, ruling that an organism incapable of developing into a human is not an embryo and may be patented.

EU's top court opens door to some stem cell patents

(Reuters) — Europe's top court today opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of developing into a human being is not a human embryo and may be patented.

2014: The year of the medtech IPO | Medtech Wall Street news for the week of December 15, 2014

December 18, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Year in review: 2014 was the year of the medtech IPO; Symmetry Medical closes surgical spinout, OEM sale; Inogen affirms 2014 outlook, predicts 2015 growth of up to 25%

FDA warns on 'keepsake' ultrasounds

December 18, 2014 by Mark Hollmer

The FDA warns consumers about the health risks of so-called "keepsake" fetal ultrasound imaging and over-the-counter fetal heartbeat monitors.

FDA warns on 'keepsake' ultrasounds

The FDA wants to dissuade expecting parents from using unregulated fetal ultrasound devices to create "keepsake" images or monitor their babies' heartbeats at home, warning that the devices pose serious risks in untrained hands.

MassDevice.com +3 | The top 3 medtech stories for December 17, 2014

December 17, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Varian nabs German cancer screening software maker MeVis Medical

December 17, 2014 by Brad Perriello

Varian Medical Systems says it agreed to pay $37 million to acquire German cancer screening software maker MeVis Medical Solutions.

Varian nabs German cancer screening software maker MeVis Medical
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp